Dr. Faith E. Davies, MD | New York, NY | HematologistUS News Health
health.usnews.com
San-Miguel, Pia Sondergeld, Pieter Sonneveld, Miklós Udvardy, Antonio Palumbo. The genetic architecture of multiple myeloma. Gareth J. Morgan, Brian A Walker ... San-Miguel, Pia Sondergeld, Pieter Sonneveld, Miklós Udvardy, Antonio Palumbo. The genetic architecture of multiple myeloma. Gareth J. Morgan, Brian A Walker ...
Dr. Gareth J. Morgan, Pediatric Cardiologist in Aurora, CO | US ...health.usnews.com › Doctors
health.usnews.com
... Torben Plesner, Jesús F. San Miguel, Ofer Shpilberg, Pia Sondergeld, Pieter Sonneveld, Sonja Zweegman; Balloon expandable stent implantation for native ...
Oncologist®Ankara Üniversitesi
avesis.ankara.edu.tr
von H Ludwig · · Zitiert von: 44 — Pieter Sonneveld, Miklos Udvardy, Pia Sondergeld. Manuscript writing: Heinz Ludwig, Meral Beksac, Joan Bladé, Jamie D. Cavenagh, Michele Cavo, Michel ... von H Ludwig · · Zitiert von: 44 — Pieter Sonneveld, Miklos Udvardy, Pia Sondergeld. Manuscript writing: Heinz Ludwig, Meral Beksac, Joan Bladé, Jamie D. Cavenagh, Michele Cavo, Michel ...
Academia–PharmaIntersect: Myelomas - The Oncologist
theoncologist.onlinelibrary.wiley.com
von H Ludwig · · Zitiert von: 149 — JESÚS SAN MIGUEL,s OFER SHPILBERG,t PIA SONDERGELD,u PIETER SONNEVELD,v SONJA ZWEEGMAN w. aWilhelminenspital, Vienna, Austria; bAnkara University School of ... › pdfdirect
European perspective on multiple myeloma treatment strategies ...
europepmc.org
... Urs Hess,o Ulf-Henrik Mellqvist,p Philippe Moreau,q Jesús San-Miguel,rPia Sondergeld,s Pieter Sonneveld,t Miklos Udvardy,u and Antonio Palumbod ... › PMC › PM...
Practical Considerations for the Use of Daratumumab, a Novel ...
link.springer.com
von P Moreau · · Zitiert von: 44 — Pia Sondergeld. Erasmus MC Cancer Insitute, Rotterdam, The Netherlands. Pieter Sonneveld. University Hospital of Salamanca, Salamanca, Spain. › article
Oncologist - BioMedSearch
www.biomedsearch.com
JESÚS SAN MIGUEL,s OFER SHPILBERG,t PIA SONDERGELD,u PIETER ... Cilag; Ofer Shpilberg: None; Pia Sondergeld: None; Pieter Sonneveld: ...
Practical Considerations for the Use of Daratumumab, a Novel CD38...
link.springer.com
· Pia Sondergeld received payment from Janssen for the writing of this manuscript. Pieter Sonneveld received Grants from Amgen, Celgene, ...
Practical Considerations for the Use of Daratumumab SpringerLinklink.springer.com › article
link.springer.com
· ... Antonio Palumbo ,; Thierry Facon ,; Torben Plesner ,; Meletios Dimopoulos ,; Pia Sondergeld ,; Pieter Sonneveld &; María-Victoria Mateos.
Alle Infos zum Namen "Pia Sondergeld"
Anti-CD38 Antibody Therapy: Windows of Opportunity ...OUCI
ouci.dntb.gov.ua
... Pia Sondergeld, Pieter Sonneveld, María-Victoria Mateos. https://doi.org s · , Drugs, № 8, p Scopus. WoS. Crossref Pia Sondergeld, Pieter Sonneveld, María-Victoria Mateos. https://doi.org s · , Drugs, № 8, p Scopus. WoS. Crossref ...
Current multiple myeloma treatment strategies with novel ...Syddansk Universitet
portal.findresearcher.sdu.dk
... Pia Sondergeld, Pieter Sonneveld, Sonja Zweegman Vis 4 andre. Vis mindre. Det Sundhedsvidenskabelige Fakultet · IRS - Sygehus Lillebælt, Forskningsenhed for Pia Sondergeld, Pieter Sonneveld, Sonja Zweegman Vis 4 andre. Vis mindre. Det Sundhedsvidenskabelige Fakultet · IRS - Sygehus Lillebælt, Forskningsenhed for ...
Current multiple myeloma treatment strategies with novel ...אוניברסיטת אריאל
cris.ariel.ac.il
... Pia Sondergeld, Pieter Sonneveld, Sonja Zweegman Show 4 others. Show less. Research output: Contribution to journal › Review article › peer-review. 91 Scopus Pia Sondergeld, Pieter Sonneveld, Sonja Zweegman Show 4 others. Show less. Research output: Contribution to journal › Review article › peer-review. 91 Scopus ...
Multiple Myeloma Treatment Strategies with Novel Agents ...Minso Solutions AB
ci.minso.se
... Hila Magen‐Nativ, Larisa Mendeleeva, Hareth Nahi, Torben Plesner, Jesús San‐Miguel, Pieter Sonneveld, Miklos Udvardy, Pia Sondergeld, Antonio Palumbo Hila Magen‐Nativ, Larisa Mendeleeva, Hareth Nahi, Torben Plesner, Jesús San‐Miguel, Pieter Sonneveld, Miklos Udvardy, Pia Sondergeld, Antonio Palumbo.
Practical Considerations for the Use of Daratumumab, a ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von P Moreau · · Zitiert von: 50 — ... Pia Sondergeld , Pieter Sonneveld , María-Victoria Mateos. Affiliations. 1 Hematology Department, University Hospital Hôtel-Dieu, Place Ricordeau ... von P Moreau · · Zitiert von: 50 — ... Pia Sondergeld , Pieter Sonneveld , María-Victoria Mateos. Affiliations. 1 Hematology Department, University Hospital Hôtel-Dieu, Place Ricordeau ...
Prezentacje / Artykuły - Centrum Leczenia SzpiczakaFundacja Centrum Leczenia Szpiczaka
archiwum.szpiczak.org
... Pia Sondergeld, Pieter Sonneveld, Miklos Udvardy, Antonio Palumbo - © The Oncologist 2012, PDF - 1,16 MB. An intermediate-risk multiple myeloma subgroup is Pia Sondergeld, Pieter Sonneveld, Miklos Udvardy, Antonio Palumbo - © The Oncologist 2012, PDF - 1,16 MB. An intermediate-risk multiple myeloma subgroup is ...
Erratum to: Practical Considerations for the Use of Daratumumab, a ...
portal.findresearcher.sdu.dk
... Christoph Driessen, Antonio Palumbo, Thierry Facon, Torben Plesner, Meletios Dimopoulos, Pia Sondergeld, Pieter Sonneveld, María-Victoria Mateos. › ...
Practical Considerations for the Use of Daratumumab, a Novel ...research.vumc.nl › publications › practical-consider...
research.vumc.nl
... Heinz Ludwig, Christoph Driessen, Antonio Palumbo, Thierry Facon, Torben Plesner, Meletios Dimopoulos, Pia Sondergeld, Pieter Sonneveld, Maria-Victoria ...
WikiGenes -
www.wikigenes.org
... Goldschmidt, Urs Hess, Ulf-Henrik Mellqvist, Philippe Moreau, Jesús San-Miguel, Pia Sondergeld, Pieter Sonneveld, Miklos Udvardy, Antonio Palumbo, ...
sortiert nach Relevanz / Datum